News
01-11-2012, 04:34 AM
Researchers at Johns Hopkins have shown that DNA changes in a gene that drives the growth of a form of lung cancer can make the cancer's cells resistant to cancer drugs.
More... (http://www.news-medical.net/news/20120111/Erlotinib-better-for-treatment-of-non-small-cell-lung-cancers-associated-with-altered-forms-of-EGFR-protein.aspx)
More... (http://www.news-medical.net/news/20120111/Erlotinib-better-for-treatment-of-non-small-cell-lung-cancers-associated-with-altered-forms-of-EGFR-protein.aspx)